Reticuloendothelial system Fc receptor function in the drug induced lupus erythematosus syndrome

Area of Science:

• Immunology
• Rheumatology
• Pharmacology

Background:

• Systemic lupus erythematosus (SLE) is associated with delayed clearance of IgG-sensitized erythrocytes.
• Drug-induced lupus erythematosus (DILE) shares some features with SLE but its immune clearance mechanisms are less understood.

Purpose of the Study:

• To investigate the clearance rate of IgG-sensitized autologous erythrocytes in patients with drug-induced lupus erythematosus (DILE).
• To determine if erythrocyte clearance is associated with disease symptoms or laboratory markers in DILE.

Main Methods:

• Measured the clearance half-time (t1/2) of 51Cr-labeled IgG-sensitized autologous erythrocytes in 16 DILE patients and 16 healthy controls.
• Assessed association of t1/2 with clinical symptoms, laboratory abnormalities, C1q, and DNA binding levels.

Main Results:

• The mean erythrocyte clearance half-time in DILE patients (52 min) was not significantly different from healthy controls (48 min).
• Erythrocyte clearance was similar in DILE patients with only laboratory abnormalities versus those with symptoms.
• No significant association was found between clearance half-time and C1q or DNA binding levels.

Conclusions:

• Patients with drug-induced lupus erythematosus exhibit normal clearance of model immune complexes (IgG-sensitized erythrocytes).
• This normal clearance mechanism may offer protection against severe organ damage, such as renal or central nervous system disease, in DILE.